To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Read more about To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke Read more about AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score Read more about Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome Read more about Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial Read more about Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2 Read more about WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2
Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects Read more about Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects